Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 29.90 | 38.76 | 53.56 | 34.81 |
Total Revenue | 29.90 | 38.76 | 53.56 | 34.81 |
Costof Revenue Total | 16.68 | 21.37 | 36.43 | 17.78 |
Gross Profit | 13.22 | 17.39 | 17.13 | 17.04 |
Selling/ General/ Admin Expenses Total | 5.52 | 5.69 | 5.77 | 5.63 |
Depreciation/ Amortization | 1.03 | 0.92 | 0.93 | 0.87 |
Other Operating Expenses Total | 8.35 | 8.99 | 7.82 | 8.27 |
Total Operating Expense | 31.58 | 36.96 | 50.95 | 32.55 |
Operating Income | -1.68 | 1.79 | 2.61 | 2.27 |
Interest Inc( Exp) Net- Non- Op Total | -8.72 | -2.61 | -3.47 | -3.81 |
Other Net | 0.64 | -0.65 | 0.24 | -0.05 |
Net Income Before Taxes | -1.92 | 0.89 | 2.62 | 1.68 |
Provisionfor Income Taxes | -0.55 | 0.23 | 0.74 | 0.59 |
Net Income After Taxes | -1.36 | 0.65 | 1.88 | 1.08 |
Net Income Before Extra Items | -1.36 | 0.65 | 1.88 | 1.08 |
Net Income | -1.36 | 0.65 | 1.88 | 1.08 |
Total Adjustmentsto Net Income | 0.00 | 0.00 | - | - |
Income Availableto Com Excl Extra Ord | -1.36 | 0.65 | 1.88 | 1.08 |
Income Availableto Com Incl Extra Ord | -1.36 | 0.65 | 1.88 | 1.08 |
Diluted Net Income | -1.36 | 0.65 | 1.88 | 1.08 |
Diluted Weighted Average Shares | 0.44 | 0.44 | 0.44 | 0.44 |
Diluted EPS Excluding Extra Ord Items | -3.07 | 1.47 | 4.24 | 2.44 |
Diluted Normalized EPS | -3.07 | 1.47 | 4.05 | 2.68 |
Gain( Loss)on Saleof Assets | - | 0.00 | 1.18 | -1.63 |
Link Pharma Chem Dividend Link Pharma Chem Bonus Link Pharma Chem News Link Pharma Chem AGM Link Pharma Chem Rights Link Pharma Chem Splits Link Pharma Chem Board Meetings Link Pharma Chem Key Metrics Link Pharma Chem Shareholdings Link Pharma Chem Balance Sheet Link Pharma Chem Cashflow Link Pharma Chem Q1 Results Link Pharma Chem Q2 Results Link Pharma Chem Q3 Results Link Pharma Chem Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks